CD44 and cancer: In the present study, we extended the previous investigation and developed the EOC CSC vaccines from human HO8910 CD117+CD44+ CSC line and murine ID8 EOC suspension sphere cells that were thought to be cancer stem-like cells [17, 18] in order to avoid the vaccine immunogenic deviation due to the different origin cells.